Did You Know...
...that "patent leather" got its name because the process of applying the polished black finish to leather was once patented?
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 4083973 | Pharmaceutical preparation adapted for oral administration The invention relates to a novel pharmaceutical preparation with anabolic activity adapted for oral administration comprising a nandrolone (= 19-nor-testosterone)-17ଲ-ester, the ester group of which has been derived from aliphatic carboxylic acids h... | 04/11/1978 |
| 4079133 | Safer method for dissolving gallstones combining hyodeoxycholic acid with chenodeoxycholic acids The administration of hyodeoxycholic acid (HDCA) with chenodeoxycholic acid (CDCA) effects a lowering of serum glutamic-oxaloacetic transaminase, serum glutamic-pyruvate transaminase and alkaline phosphatase in the blood relative to the administration of ... | 03/14/1978 |
| 4076811 | Novel agents and methods for treatment of climacteric disturbances Reliable relief of physical and psychological menopausal disturbances is achieved by administering a combination of estradiol estrogen or derivatives of estradiol (type 1) and estriol or a derivative of estriol (type 2) in a ratio of approximately 1 : 1 t... | 02/28/1978 |
| 4075334 | 6ଲ-Iodomethyl-19-norcholest-5(10)-en-3ଲ-ol and compositions containing same Iodinated compounds useful for photoscanning the adrenal glands.... | 02/21/1978 |
| 4075233 | 16-Dehydro steroids of the androstane series Therapeutically useful 16-dehydro-androstane derivatives of the general formula: ##STR1## processes for their preparation and pharmaceutical compositions for the treatment of dermatological disorders, which contain as active ingredient at least ... | 02/21/1978 |
| 4071623 | Pharmaceutical preparation adapted for oral administration The invention relates to a novel pharmaceutical preparation with oestrogenic activity adapted for oral administration comprising an oestradiol-17ଲ-ester, the ester group of which has been derived from aliphatic carboxylic acids having 9-16 carbon at... | 01/31/1978 |
| 4060606 | 16-Ethers of fusidic acid derivatives The present invention relates to a new series of fusidic acid derivatives, to salts and easily hydrolysable esters thereof, to the preparation of these compounds, and to pharmaceutical compositions containing the compounds. The new compounds have the gene... | 11/29/1977 |
| 4002747 | Novel ester of 19-nor-testosterone The invention relates to a novel di-ester of 19-nor-testosterone and the preparation thereof. The novel di-ester, i.e. the 2',2" -oxydiacetate, is a strong anabolic agent.... | 01/11/1977 |
| 3969503 | Compositions and methods useful in rendering lithogenic mammalian bile non-lithogenic A method of rendering mammalian bile non-lithogenic which comprises administering to a mammal having lithogenic bile, a small but effective amount of a compound of the formula ##SPC1## Wherein each Y is hydrogen; each X is selected from the group consisti... | 07/13/1976 |
| 3969502 | Method for contraception by the administration of sequential contraceptive preparations Method of contraception over a 21-day cycle in which an estrogen and a progestogen are administered in a low dosage for 10-12 days and thereafter at a slightly higher dosage for the next 11-9 days.... | 07/13/1976 |
| 3957982 | Method for contraception by the application of combination-type sequential preparations Method of contraception in which an estrogen and a progestagen are orally administered daily for 21 days, the first 4-6 days at a low contraceptively effective daily dose, the next 4-6 days at a daily estrogen dose 1-2 times and a daily progestrogen dose ... | 05/18/1976 |
| 3942641 | Dispensing packages containing novel cyclic progestogen-interrupted estrogen oral contraceptive regimens This invention relates to a method of fertility control by use of novel cyclic progestogen-interrupted estrogen oral contraceptive regimens. Considering the first day of menstrual flow as day one of a 28 day medication administration cycle, a combined for... | 03/09/1976 |
| 3939264 | Method for contraception by the administration of sequential contraceptive preparations Oral contraceptive consisting essentially in admixture with a pharmaceutically acceptable carrier, of 21-23 separate dosage units adapted for oral ingestion, containing an amount of an estrogen corresponding in activity to 0.030-0.050 mg. 17-ethiny... | 02/17/1976 |
| 3939265 | Novel zootechnical compositions Novel zootechnical compositions and a method of upgrading of domestic animals such as cattle by administering under the skin of cattle a mixture of an anabolisant steroid of the formula ##SPC1## Wherein R is alkyl of 1 to 4 carbon atoms and X is selected ... | 02/17/1976 |
| 3934013 | Pharmaceutical composition This invention relates to a topical, anti-inflammatory, pharmaceutical composition which comprises (a) a pharmaceutically acceptable solvent, e.g. propylene glycol and water, and (b) at least two corticosteroids chosen from those represented by formulas A... | 01/20/1976 |
| 3932635 | Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens This invention relates to a method of fertility control by use of novel cyclic progestogen-interrupted estrogen oral contraceptive regimens. Considering the first day of menstrual flow as day one of a 28 day medication administration cycle, a combined for... | 01/13/1976 |
